Navigation Links
Strategic Alliance Between Televisa and Genomma Lab
Date:10/9/2009

MEXICO CITY, Oct. 9 /PRNewswire-FirstCall/ -- Genomma Lab Internacional, S.A.B. de C.V. ("Genomma") (BMV: LAB) announced today the successful completion of the Strategic Alliance Agreement with Grupo Televisa, S.A.B. (NYSE: TV; BMV: TLEVISA CPO), which was announced on August 30, 2009, to sell and distribute personal care, cosmetics and over-the-counter pharmaceuticals in the United States and Puerto Rico.

The parties expect to launch operations during the first quarter of 2010.

Company Description:

Genomma Lab Internacional, S.A.B. de C.V. is one of the fastest growing pharmaceutical and personal care products companies in Mexico and has a growing international presence. Genomma develops, sells and markets a broad range of premium branded products, many of which are leaders in the categories in which they compete in terms of sales and market share. The Company has significantly grown its revenue and profitability through a combination of a successful new product development process, consumer-oriented marketing, a broad retail distribution network and a low-cost, highly flexible operating model.

    IR Contact: Oscar Villalobos
    Tel: +52 (55) 5081-0000 ext. 4250
    E-mail: inversion@genommalab.com

    In New York: i-advize Corporate Communications, Inc.
    Tel: (212) 406-3692
    E-mail: genomma@i-advize.com

SOURCE Genomma Lab Internacional, S.A.B. de C.V.


'/>"/>
SOURCE Genomma Lab Internacional, S.A.B. de C.V.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
2. Martopia(R) Forms Strategic Alliance With Modern Healthcare Magazine
3. LehmanMillet Continues Expansion with Strategic Hires
4. Stille and Enova Form Strategic Partnership to Introduce Worlds Brightest LED Cordless Surgical Headlights Into Europe and Japan
5. Benjamin England, Former FDA Regulatory Counsel, to Testify on FDA Import Strategic Plan Before House Appropriations Subcommittee
6. Diet.com Enters Strategic Collaboration To Support Microsoft HealthVault
7. Lumenis Ltd. Announces Senior Leadership Appointments Strengthening the Companys Strategic Businesses
8. Avantium and BP Extend Strategic Partnership
9. 40 86 Strategic Income Fund Declares Dividend
10. Medco, LabCorp Strike Strategic Agreement for Research on Personalized Medicine and Pharmacogenomics
11. Cogon Systems Supports the Pensacola Bay Area Chamber of Commerce with the Strategic Health Intelligence Summit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... 28, 2017 , ... It's not always common knowledge whether or not a ... unclear as to whether or not they are contagious, and most people don't know ... So, FindaTopDoc took a look into the matter. , They discovered that the ...
(Date:4/28/2017)... New York, NY (PRWEB) , ... April 28, ... ... Shiel Medical Laboratory to expanded distribution of the GlycoMark test throughout the Northeast ... indicates recent hyperglycemia in patients with diabetes. The GlycoMark test provides a clinically ...
(Date:4/28/2017)... , ... April 28, 2017 , ... ... been previously exposed to more adverse experiences than children in the general population. ... such as abuse, neglect or other family challenges. While no fault of their ...
(Date:4/28/2017)... ... ... Bill Howe started his sewer and drain company in 1980 focusing heavily ... team, the Bill Howe brand was born and they began cultivating their mission to ... the San Diego community in which they worked, lived and were raising their daughters. ...
(Date:4/28/2017)... ... April 28, 2017 , ... Woolsy Corporation ... supplements, through its Nova Skin Sciences division, recently announced the launch of Allumière ... with the power of an anti-aging concentrate. , Anogeissus Leiocarpa Bark ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Texas , April 20, 2017  Vivify Health, ... mobile devices, has been awarded a very significant patent ... via EMRs to continual care via digital health.  This ... key intellectual property and further secures Vivify,s position as ... launched in 2009, was the first company to apply ...
(Date:4/20/2017)... 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), a ... significant unmet medical needs, today announced that it ... product development program, based on its proprietary self-delivering ... Dermatology (SID) 76 th Annual Meeting.  The ... sciences relevant to skin health and disease through ...
(Date:4/20/2017)... , April 20, 2017   ZappRx, Inc ., ... specialty drug prescribing process, today announced it closed $25 million ... a venture capital firm based in Seattle ... Qiming Venture Partners . The Series B round included participation ... round in 2014, and GV (formerly Google Ventures). ...
Breaking Medicine Technology: